The p53-mediated DNA damage response to ionizing radiation in fibroblasts from ataxia-without-telangiectasia patients

International Journal of Radiation Biology

Volumn 74, Issue 3, 1998, Pages 287-295

  Jongmans, W ^a,d   Vuillaume, M ^a   Kleijer, W J ^b   Lakin, N D ^c   Hall, J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN P53;

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CEREBELLAR ATAXIA; DNA DAMAGE; FEMALE; FIBROBLAST CULTURE; GENE MUTATION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; IONIZING RADIATION; LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0031711843     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098141438     Document Type: Article

References (37)

1. ARTUSO, M., ESTEVE, A., BRÉSIL, H., VUILLAUME, M. and HALL, J., 1995, The role of the ataxia-telangiectasia gene in the p53, WAF/CIP1(p21) and GADD45-mediated response to ionising radiation. Oncogene, 11, 1427-1435.
2. BAUMER, A., BERNTHALER, U., WOLZ, W., HOEHN, H. and SCHINDLER, D., 1996, New mutations in the ataxia-telangiectasia gene. Human Genetics, 98, 246-249.
3. BODER, E. and SEDGWICK, R. P., 1957, Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infections. A premilinary report on 7 children, and autopsy, and a case history. University of South California Medical Bulletin, 9, 15-28.
4. BYRD, P. J., MCCONVILLE, C. M., COOPER, P., PARKNILL, J., STANKOVIC, T., MCGUIRE, G. M., THICK, J. A. and TAYLOR, A. M. R., 1995, Mutations revealed by sequencing the 5′ half of the gene for ataxia-telangiectasia. Human Molecular Genetics, 5, 145-149.
5. BYRNE, E., HALLPIKE, J. F., MANSON, J. I., SUTHERLAND, G. R. and THONG, Y. H., 1984, Ataxia-without-telangiectasia. Journal of Neurological Science, 66, 307-317.
6. CHESSA, L., PETRINELLI, P., ANTONELLI, A., FIORILLI, M., ELLI, L., MARCUCCI, L., FEDERICO, A. and GANDINI, E., 1992, Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediated cellular radiosensitivity. American Journal of Medical Genetics, 42, 741-746.
7. DE GRAAF, A. S., DE JONG, G. and KLEIJER, W. J., 1995, An early-onset recessive cerebellar disorder with distal amyotrophy and, in two patients, gross myoclonia: a probable ataxia-telangiectasia variant. Clinical Neurology and Neurosurgery, 97, 1-7.
8. FIORILLI, M., ANTONELLI, A., RUSSO, G., CRESCENZI, M., CARBONARI, M. and PETRINELLI, P., 1985, Variant of ataxia-telangiectasia with low-level radiosensitivity. Human Genetics, 70, 274-277.
9. GILAD, S., CHESSA, L., KHOSRAVI, R., RUSSELL, P., GALANTY, Y., PIANE, M., GATTI, R. A., JORGENSEN, T., J., SHILOH, Y. and BAR-SHIRA, A., 1998, Genotype phenotype relationships in ataxia-telangiectasia and variants. American Journal of Human Genetics, 62, 551-561.
10. GILAD, S., KHOSRAVI, R., SHKEDY, D., UZIEL, T., ZIV, Y., SAVITSKY, K., ROTMAN, G., SMITH, S., CHESSA, L., JORGENSEN, T. J., HARNIK, R., FRYDMAN, M., SANAL, O., PORTNOI, S., GOLDWICZ, Z., JASPARS, N. G., GATTI, R. A., LENOIR, G., LAVIN, M. F., TATSUMI, K., WEGNER, R. D., SHILOH, Y. and BAR-SHIRA, A., 1996, Predominance of null mutations in ataxia-telangiectasia. Human Molecular Genetics, 5, 433-439.
11. JEGGO, P. A., TACCIOLI, G. E. and JACKSON, S. P., 1995, Menage a trois: double strand break repair, V(D)J recombination and DNA-PK. Bioessays, 17, 949-957.
12. JONGMANS, W., ARTUSO, M., VUILLAUME, M., BRÉSIL, H., JACKSON, S. P. and HALL, J., 1996, The role of ataxia-telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionising radiation. Oncogene, 13, 1133-1138.
13. JONGMANS, W., VUILLAUME, M., CHRZANOWSKA, K., SMEETS, D., SPERLING, K. and HALL, J., 1997, Nijmegen Breakage Syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionising radiation. Molecular and Cellular Biology, 17, 5016-5022.
14. JUNG, M., KONDRATYEV, A., LEE, S. A., DIMTCHEV, A. and DRITSCHILO, A., 1997, ATM gene product phosphorylates IκB-α. Cancer Research, 57, 24-27.
15. KASTAN, M. B., ZHAN, Q., EL-DEIRY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J., 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
16. KEEGAN, K. S., HOLTZMAN, D. A., PLUG, A. W., CHRISTENSON, E. R., BRAINERD, E. E., FLAGGS, G., BENTLEY, N. J., TAYLOR, E. M., MEYN, M. S., MOSS, S. B., CARR, A. M., ASHLEY, T. and HOEKSTRA, M. F., 1996, The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes and Development, 10, 2423-2437.
17. KHANNA, K. K. and LAVIN, M. F., 1993, Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene, 8, 3307-3312.
18. KIRSCH, I. R., 1994, V(D)J recombination and ataxia-telangiectasia: a review. International Journal of Radiation Research, 66, S97-S108.
19. LAKIN, N. D., WEBER, P., STANKOVIC, T., ROTTINGHAUS, S. T., TAYLOR, A. M. R. and JACKSON, S. P., 1996, Analysis of the ATM protein in wild-type and ataxia-telangiectasia cells. Oncogene, 13, 2707-2716.
20. LEE, S. E., MITCHELL, R. A., CHENG, A. and HENDRICKSON, E. A., 1997, Evidence for DNA-PK dependent and independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Molecular and Cellular Biology, 17, 1425-1433.
21. LI, Z., DORDAI, D. I., LEE, J. and DESIDERIO, S., 1997, A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity, 5, 575-589.
22. MASERATI, E., OTTOLIN, A., VEGGIOTTI, P., LANZI, G. and PASQUALI, F., 1988. Ataxia-without-telangiectasia in two sisters with rearrangements of chromosomes 7 and 14. Clinical Genetics, 34, 283-287.
23. MCCONVILLE, C. M., STANKOVIC, T., BYRD, P. J., MCGUIRE, G. M., YAO, Q.-Y., LENNOX, G. G. and TAYLOR, A. M. R., 1996, Mutations associated with variant phenotypes in ataxia-telangiectasia. American Journal of Human Genetics, 59, 320-330.
24. SAVITSKY, K., BAR-SHIRA, A., GILARD, S., ROTMAN, G., ZIV, Y., VANAGAITE, L., TAGLE, D. A., SMITH, S., UZIEL, T., SFEZ, S., ASHKENAZI, M., PECKER, I., FRYDMAN, M., HARNIK, R., PATANSALI, S. R., SIMMONS, A., CLINES, G. A., SARTIEL, A., GATTI, R. A., CHESSA, L., SANAL, O., LAVIN, M. F., JASPERS, N. G. J., TAYLOR, A. M. R., ARLETT, C. F., MIKI, T., WEISSMAN, S., LOVETT, M., COLLINS, F. S. and SHILOH, Y., 1995, A single ataxia-telangiectasia gone with a product similar to PI 3-kinase. Science, 268, 1749-1753.
25. SCHLISSEL, M., CONSTANTINESCU, A., MORROW, T., BAXTER, M. and PENG, A., 1993, Double-strand signal sequence breaks in V(D)J recombination are blunt 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes and Development, 7, 2520-2532.
26. SEDGWICK, R. P. and BODER, E., 1991, Ataxia-telangiectasia. In Hereditary Neuropathies and Spinocerebellar Atrophies, Handbook of Clinical Neurology, Volume 16, edited by J. M. B. V. De Jong (Amsterdam/New York: Elsevier Science Publishers B.V.), pp. 347-423.
27. SHAFMAN, T. D., SALEEM, A., KYRIAKIS, J., WEICHSELBAUM, R., KHARBANDA, S. and KUFE, D. W., 1995, Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionising radiation. Cancer Research, 55, 3242-3245.
28. SHILOH, Y., 1995, Ataxia-telangiectasia: closer to unraveling the mystery. European Journal Human Genetics, 3, 116-138.
29. STANKOVIC, T., KIDD, A. M. J., SUTCLIFFE, A., MCGUIRE, G. M., ROBINSON, P., WEBER, P., BEDENHAM, T., BRADWELL, A. R., EASTON, D. F., LENNOX, G. G., HAITES, N., BYRD, P. J. and TAYLOR, A. M. R., 1998, ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant AFM and the risk of leukemia, lymphoma, and breast cancer. American Journal of Human Genetics, 62, 334-345.
30. TAYLOR, A. M. R., FLUDE, E., LAHER, B., STACEY, M., MCKAY, K., WATT, J., GREEN, S. H., and HARDING, A. E., 1987, Variant forms of ataxia-tclangiectasia. Journal of Medical Genetics, 24, 669-677.
31. TELATAR, M., WANG, Z., UDAR, N., LIANG, T., BERNATOWSKA-MATUSZKIEWICZ, E., LAVIN, M., SHILOH, Y., CONCANNON, P., GOOD, R. A. and GATTI, R. A., 1996. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein truncation screening. American Journal of Human Genetics, 59, 40-44.
32. TELATAR, M., TEROAKA, S., WANG, S., CHUN, H. H., LIANG, T., CASTELLVI-BEL, S., UDAR, N., BORRESEN-DALE, A.-L., CHESSA, L., BERNATOWSKA-MAUSZKIEWICZ, E., PORRAS, O., WATANABE, M., JUNKER, A., CONCANNON, P. and GATTI, R. A., 1998, Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. American Journal of Human Genetics, 62, 86-97.
33. WATTERS, D., KHANNA, K. K., BEAMISH, H., BIRREL, G., SPRING, K., KEDAR, P., GATEL, M., STENZEL, D., HOBSON, K., KOZLOV, S., ZHANG, N., FARRELL, A., RAMSAY, J., GATTI, R. and LAVIN, M., 1997, Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene, 14, 1911-1921.
34. WILLEMS, P. J., VAN ROY, B. C., KLEIJER, W. J., VAN DER KRAAN, M. and MARTIN, J. J., 1993. Atypical clinical presentation of ataxia-telangiectasia. American Journal Medical Genetics, 45, 777-782.
35. WRIGHT, J., TERAOKA, S., ONENGUT, S., TOLUN, A., GATTI, R. A., OCHS, H. D. and CONCANNON, P., 1996. A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. American Journal of Human Genetics, 59, 839-846.
36. YING, K. L. and DECOTEAU, W. E., 1983, Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia. Cancer Genetics and Cytogenetics, 4, 311-317.
37. ZIV, Y., AMIEL, A., JASPERS, N. G. J., BERKEL, A. I. and SHILOH, Y., 1989, Ataxia-telangiectasia: a variant with altered in vitro phenotype of fibroblast cells. Mutation Research, 210, 211-219.